Click to Share

Filter News
Show All Results
News By Country
News By Tag
Pharmaceutical Company Remove

April 2017

Public Company News

Business Press Releases

Pharmaceutical Company Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Rablon Healthcare Pvt Ltd
Rablon healthcare is a worldwide leading pharmaceutical organization that is situated in India which has showcased potential results in the manufacturing & distribution environment.
By Rablon Healthcare Pvt Ltd
Rablon healthcare is a leading pharmaceutical organization in India that has outshone powerful results in its field to manufacturing of the drugs & its proper distribution through effective channels.
By ccminternational
China is the second highest cancer-incidence country in the world with over 2.2 million new cancer cases every year.
By Robert Thornhill
Mystery author, Robert Thornhill releases the fifth installment in his Lady Justice mystery/comedy series
The podcast is an insightful analysis of pharma outsourcing and includes comments on attractive partners, service providers, keeping strength, maintaining core specialties and the future for the industry.
By S.Raju
The report analyzes the sector by market value, market share, market segmentation, key drivers, trends and positioning. It includes details of the top 10 companies in the industry along with five-year financial analysis and in-depth SWOT profiles.
By S.Raju
“Global Bioinformatics Market Outlook” is an outcome of an in-depth research and rational analysis of the global bioinformatics market and key active market players. It investigates the current market trends in key countries.
By S.Raju
“Global Pharmaceutical Market Forecast to 2012” provides a comprehensive analysis of every major pharmaceutical market worldwide. North America, Latin America, Europe, Asia-Pacific, and MENA are selected as the important regions to be discussed.
By Press-service of Artur-K
In Odessa, on 16-18 of September, was held first congress of urologists with participation of Ukrainian and foreign representatives under the aegis of Ministry of HealthCare, Association of urologists of Ukraine and other national institutions.
By Darina Chayka
The company “Artur-K” became one of the leaders according to the rate “TOP-100. Leaders of business in Ukraine – 10 years of development.”
By Darina Chayka
The company “Artur-k” took part in Central and Eastern Europe Wholesalers Summit arranged by “Sandoz”. Among invited there were the biggest pharmaceutical companies of Central and Western Europe.
By TiEcon SV
Dr. Reddy, pioneering pharmaceutical entrepreneur built India’s 2nd largest pharmaceutical company(NYSE:RDY) speaks at TIEcon.
By Rachel Wells
Specialty pharmaceutical company releases new product for Allergic Rhinitis
By Dr. Reddy's Laboratories Ltd
Dr. Reddy’s has launched Supanac ® (Diclofenac potassium immediate release 50 mg tablets) in India, increasing its offering in the Rs 2700 crores (~ $688 million) NSAID market. (Source: IMS ORG June MAT ’07).
By Dr. Reddy's Laboratories Ltd
Dr. Reddy’s announces settlement of Exelon (rivastigmine tartrate) ANDA litigation with Novartis
By Dr.Reddy's Laboratories Ltd.
Argenta Discovery Limited, the respiratory drug discovery and development company, and Dr Reddy’s Laboratories (NYSE: RDY), today announce a major milestone in their development programme
By Dr.Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the second quarter ended September 30, 2007 on Wednesday
By Dr.Reddy's Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited financial results for the quarter ended September 30, 2007.
By Dr.Reddy's Laboratories Ltd
Dr. Reddy’s Laboratories Limited (NYSE: RDY) announces that the company’s annual report on Form 20-F for the year ended March 31, 2007 is available on its website ( )
By Dr.Reddy's Pharmaceutical Company
Dr. Reddy's Pharmaceutical Company Commences Operations in Philippines. Expands presence in the ASEAN region
By Dr.Reddy's Laboratories Ltd
Dr. Reddy’s Laboratories (NYSE:RDY) announced today, that the U.S. Food and Drug Administration (USFDA) has granted final approval for the Company’s Abbreviated New Drug Application (ANDA) for Ranitidine (Zantac™) 150mg tablet.

  • 1
Page updated every 10 minutes

Like PRLog?
Click to Share